Literature DB >> 18160573

Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step.

Abdel Terrab1, Dan Pawlak, Pat Spaay, Debra Hoppensteadt, Jawed Fareed.   

Abstract

Topical bovine thrombin is commonly used during surgery to maintain hemostasis and is rarely associated with abnormalities in hemostasis, including coagulopathies and bleeding. Coagulopathies may be related to the formation of cross-reactive antibodies to bovine factor V. Effectiveness of a new filtration step to remove factor V/Va from bovine thrombin was evaluated. A highly sensitive and specific Western blot capable of detecting minute amounts of factor V/Va and/or its fragments was developed. Samples were evaluated for bovine factor V related antigens using the Western blot method and a competitive enzyme-linked immunosorbent assay. Factor Va light chain fragment levels were detectable in crude thrombin and chromatographically purified thrombin but not in chromatographically purified and virally filtered preparations. Therefore, inclusion of the viral-filtration step during purification of thrombin is effective in reducing factor V or its fragments to undetectable levels, thus enhancing product purity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160573     DOI: 10.1177/1076029607308866

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  3 in total

1.  Safety of topical thrombins: the ongoing debate.

Authors:  Christopher Lomax
Journal:  Patient Saf Surg       Date:  2009-09-04

2.  The unresolved safety concerns of bovine thrombin.

Authors:  Aryeh Shander; Mazyar Javidroozi
Journal:  Patient Saf Surg       Date:  2008-09-22

3.  Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.

Authors:  Paul Ness; Michael Creer; George M Rodgers; Joseph J Naoum; Kenneth Renkens; Stacy A Voils; W Allan Alexander
Journal:  Patient Saf Surg       Date:  2009-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.